LGC Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:LGC Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013290
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
LGC Ltd (LGC) formerly LGC (Teddington) Limited, is a life sciences measurement and testing company which offers reference materials, genomics solutions and analytical testing products and services. Its products portfolio includes AutoGen, DNA extraction instrumentation, DNA extraction kits, Douglas scientific, genotyping chemistry, genotyping instruments, genotyping libraries and others. The company provides services such as genotyping, consultancy, consumer product testing, digital forensic investigation, DNA and RNA extraction services; DNA sequencing, drug and alcohol testing; drug development services, food and agricultural analytical services and others. The company caters to agrigenomics, forensic science, food, government and academia; human genomics, pharma and healthcare and sports sectors. It has operations across the US, Europe, Africa and Asia regions. LGC is headquartered in Teddington, Middlesex, the UK.

LGC Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
LGC Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
LGC Ltd, Medical Devices Deals, 2011 to YTD 2017 8
LGC Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
LGC Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
LGC Genomics To Acquire Bioanalytical Sciences Business Of Quotient BioResearch 10
Private Equity 11
KKR to Acquire LGC from Bridgepoint 11
Partnerships 12
EnviroLogix Enters Into Distribution Agreement With Douglas Scientific 12
Link Technologies Enters Into Distribution Agreement With GeneDesign 13
ChromaDex Enters Into Distribution Agreement With LGC Standards For LoGiCal Reference Standards 14
EnviroLogix Enters Into Co-Development Agreement With Douglas Scientific 15
Life Technologies Enters Into Co-Marketing Agreement With Douglas Scientific 16
Licensing Agreements 17
LGC Enters into Licensing Agreement with Keygene 17
Biosearch Technologies Enters Into Licensing Agreement With Rutgers University For turboFISH Technology 18
Biosearch Technologies Extends Licensing Agreement With University Of Medicine And Dentistry Of New Jersey For Stellaris RNA FISH Technology 19
Biosearch Technologies Enters Into Licensing Agreement With University of Medicine and Dentistry of New Jersey For Nucleic Acid Probe Technology 20
Acquisition 21
LGC Acquires Axolabs 21
LGC to Acquire Biosearch Technologies 22
Biosearch Technologies Acquires Majority Stake In LightSpeed Genomics 23
Management Of Axolabs Acquires The Company 24
LGC Acquires KBioscience 25
LGC Ltd – Key Competitors 26
LGC Ltd – Key Employees 27
LGC Ltd – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Joint Venture 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
LGC Ltd, Pharmaceuticals & Healthcare, Key Facts, 2015 2
LGC Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
LGC Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
LGC Ltd, Medical Devices Deals, 2011 to YTD 2017 8
LGC Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
LGC Genomics To Acquire Bioanalytical Sciences Business Of Quotient BioResearch 10
KKR to Acquire LGC from Bridgepoint 11
EnviroLogix Enters Into Distribution Agreement With Douglas Scientific 12
Link Technologies Enters Into Distribution Agreement With GeneDesign 13
ChromaDex Enters Into Distribution Agreement With LGC Standards For LoGiCal Reference Standards 14
EnviroLogix Enters Into Co-Development Agreement With Douglas Scientific 15
Life Technologies Enters Into Co-Marketing Agreement With Douglas Scientific 16
LGC Enters into Licensing Agreement with Keygene 17
Biosearch Technologies Enters Into Licensing Agreement With Rutgers University For turboFISH Technology 18
Biosearch Technologies Extends Licensing Agreement With University Of Medicine And Dentistry Of New Jersey For Stellaris RNA FISH Technology 19
Biosearch Technologies Enters Into Licensing Agreement With University of Medicine and Dentistry of New Jersey For Nucleic Acid Probe Technology 20
LGC Acquires Axolabs 21
LGC to Acquire Biosearch Technologies 22
Biosearch Technologies Acquires Majority Stake In LightSpeed Genomics 23
Management Of Axolabs Acquires The Company 24
LGC Acquires KBioscience 25
LGC Ltd, Key Competitors 26
LGC Ltd, Key Employees 27
LGC Ltd, Other Locations 28
LGC Ltd, Subsidiaries 28
LGC Ltd, Joint Venture 29

★海外企業調査レポート[LGC Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Iberdrola SA (IBE)-エネルギー分野:企業M&A・提携分析
    Summary Iberdrola, S.A. (Iberdrola) is an electric utility. The company generates, trades, transmits, distributes and markets electricity and gas. It operates hydroelectric, thermal and nuclear power plants in Spain and other countries. The company also involved in the production of electricity from …
  • Hydro One Ltd (H):企業の財務・戦略的SWOT分析
    Hydro One Ltd (H) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Novartis AG:企業の戦略・SWOT・財務情報
    Novartis AG - Strategy, SWOT and Corporate Finance Report Summary Novartis AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • VT Holdings Co Ltd (7593):企業の財務・戦略的SWOT分析
    VT Holdings Co Ltd (7593) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • GEE Group Inc (JOB):企業の財務・戦略的SWOT分析
    Summary GEE Group Inc (GEE) is a provider of professional staffing and recruiting services. The company’s staffing services comprise temporary staffing services, professional placement services, and management services. It provides direct hire, contract, and contract-to-hire services in accounting, …
  • Immunicom Inc:医療機器:M&Aディール及び事業提携情報
    Summary Immunicom Inc (Immunicom) is a specialty biotechnology company that develops non-pharmaceutical therapies for oncology and autoimmune diseases. The company offers immune inhibitors that play a key role in protecting tumors from the body’s natural immune mechanisms. It proprietary Immunophere …
  • Tatry Mountain Resorts, AS:戦略・SWOT・企業財務分析
    Tatry Mountain Resorts, AS - Strategy, SWOT and Corporate Finance Report Summary Tatry Mountain Resorts, AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Banca Sella Holding SpA:企業の戦略的SWOT分析
    Banca Sella Holding SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Aequus Pharmaceuticals Inc (AQS):企業の財務・戦略的SWOT分析
    Summary Aequus Pharmaceuticals Inc (Aequus Pharmaceuticals) is a drug discovery and development company that develops differentiated drugs. The company’s pipeline products include AQS301, AQS302 and AQS303. Its commercial pipeline comprises ophthalmology products and transplant products. Aequus Phar …
  • ShaMaran Petroleum Corp (SNM):企業の財務・戦略的SWOT分析
    Summary ShaMaran Petroleum Corp (ShaMaran Petroleum), formerly Bayou Bend Petroleum Ltd is an independent oil and gas exploration and development company. The corporation explores, produces, and develops oil and gas assets. It holds interests and operates Atrush petroleum property located in Kurdist …
  • Canada Life Ltd:企業の戦略・SWOT・財務情報
    Canada Life Ltd - Strategy, SWOT and Corporate Finance Report Summary Canada Life Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Sheetz, Inc.:企業の戦略・SWOT・財務分析
    Sheetz, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sheetz, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • B3 S.A.
    B3 S.A. - Strategy, SWOT and Corporate Finance Report Summary B3 S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • PTC Inc.:企業の戦略・SWOT・財務情報
    PTC Inc. - Strategy, SWOT and Corporate Finance Report Summary PTC Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Silex Systems Ltd (SLX):企業の財務・戦略的SWOT分析
    Summary Silex Systems Ltd (Silex) is a research and development company that offers technology solutions. The company develops, and commercializes technologies in solar energy, nuclear energy, and advanced materials and instrumentation. It develops utility-scale concentrating photovoltaic technology …
  • Hoegh LNG Holdings Ltd (HLNG):石油・ガス:M&Aディール及び事業提携情報
    Summary Hoegh LNG Holdings Ltd (Hoegh LNG), formerly Leif Hoegh & Co Ltd is an oil and gas company that offers oilfield services and floating energy solutions. The company's services include floating storage and regasification unit solutions, in-house ship management, floating LNG energy services, L …
  • Natsionalna Elektricheska Kompania EAD:企業の戦略的SWOT分析
    Natsionalna Elektricheska Kompania EAD - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • JBCC Holdings Inc (9889):企業の財務・戦略的SWOT分析
    JBCC Holdings Inc (9889) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • NV Energy Inc:企業の戦略的SWOT分析
    NV Energy Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Halliburton Co (HAL)-石油・ガス分野:企業M&A・提携分析
    Summary Halliburton Company (Halliburton) is an oilfield services company. The company serves the upstream oil and gas industry throughout the lifecycle of the reservoir, from identifying hydrocarbons and managing geological data, to drilling and formation evaluation, well construction and completio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆